Covered recipient · General Payments record
LINDSAY BLAIR OSTERGAARD
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner
General Payments · PY2021–2024
$2,539.16
- Reported across 121 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $799.60 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $586.23 | 12 |
| E.R. Squibb & Sons, L.L.C. | $112.69 | 1 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $31.05 | 1 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $22.00 | 1 |
| Lilly USA, LLC | $19.03 | 1 |
| Ardelyx, Inc. | $14.76 | 1 |
| Amgen Inc. | $13.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $123.03 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107771610 | CMS |
| ABBVIE INC. | $32.37 | 03/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107771612 | CMS |
| ABBVIE INC. | $8.79 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107771614 | CMS |
| ABBVIE INC. | $13.92 | 05/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107771616 | CMS |
| ABBVIE INC. | $123.38 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107771618 | CMS |
| ABBVIE INC. | $5.79 | 08/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107771620 | CMS |
| ABBVIE INC. | $8.16 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107771622 | CMS |
| ABBVIE INC. | $124.31 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107771624 | CMS |
| ABBVIE INC. | $7.20 | 09/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107771626 | CMS |
| ABBVIE INC. | $8.66 | 09/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107771628 | CMS |
| ABBVIE INC. | $7.70 | 10/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107771630 | CMS |
| ABBVIE INC. | $122.92 | 10/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107771632 | CMS |
| Amgen Inc. | $13.84 | 01/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117344624 | CMS |
| Ardelyx, Inc. | $14.76 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146740348 | CMS |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $31.05 | 01/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117946831 | CMS |
| E.R. Squibb & Sons, L.L.C. | $112.69 | 04/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101632757 | CMS |
| Lilly USA, LLC | $19.03 | 02/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135800146 | CMS |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $22.00 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153534774 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.